227 related articles for article (PubMed ID: 30975722)
21. Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction.
Kurabayashi M; Jeyaseelan R; Kedes L
J Biol Chem; 1994 Feb; 269(8):6031-9. PubMed ID: 8119948
[TBL] [Abstract][Full Text] [Related]
22. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
[TBL] [Abstract][Full Text] [Related]
23. LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2.
Tan YE; Xing Y; Ran BL; Zhang C; Pan SW; An W; Chen QC; Xu HM
Aging (Albany NY); 2020 Nov; 12(24):25060-25075. PubMed ID: 33206629
[TBL] [Abstract][Full Text] [Related]
24. Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program.
Lin S; Shen H; Li JL; Tang S; Gu Y; Chen Z; Hu C; Rice JC; Lu J; Wu L
J Biol Chem; 2013 Mar; 288(9):6238-47. PubMed ID: 23349461
[TBL] [Abstract][Full Text] [Related]
25. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
26. Muscle-relevant genes marked by stable H3K4me2/3 profiles and enriched MyoD binding during myogenic differentiation.
Cui H; Bansal V; Grunert M; Malecova B; Dall'Agnese A; Latella L; Gatto S; Ryan T; Schulz K; Chen W; Dorn C; Puri PL; Sperling SR
PLoS One; 2017; 12(6):e0179464. PubMed ID: 28609469
[TBL] [Abstract][Full Text] [Related]
27. Human myostatin negatively regulates human myoblast growth and differentiation.
McFarlane C; Hui GZ; Amanda WZ; Lau HY; Lokireddy S; Xiaojia G; Mouly V; Butler-Browne G; Gluckman PD; Sharma M; Kambadur R
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C195-203. PubMed ID: 21508334
[TBL] [Abstract][Full Text] [Related]
28. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
29. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist.
Hamamori Y; Wu HY; Sartorelli V; Kedes L
Mol Cell Biol; 1997 Nov; 17(11):6563-73. PubMed ID: 9343420
[TBL] [Abstract][Full Text] [Related]
30. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Lu K; Dong JL; Fan WJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
[TBL] [Abstract][Full Text] [Related]
31. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
32. Role of epithelial-mesenchymal transition regulated by twist basic helix-loop-helix transcription factor 2 (Twist2) in embryo implantation in mice.
Gou J; Hu T; Li L; Xue L; Zhao X; Yi T; Li Z
Reprod Fertil Dev; 2019 Apr; 31(5):932-940. PubMed ID: 30779884
[TBL] [Abstract][Full Text] [Related]
33. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
[TBL] [Abstract][Full Text] [Related]
34. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
35. Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c.
Lee YS; Lee HH; Park J; Yoo EJ; Glackin CA; Choi YI; Jeon SH; Seong RH; Park SD; Kim JB
Nucleic Acids Res; 2003 Dec; 31(24):7165-74. PubMed ID: 14654692
[TBL] [Abstract][Full Text] [Related]
36. SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.
Skrzypek K; Kusienicka A; Trzyna E; Szewczyk B; Ulman A; Konieczny P; Adamus T; Badyra B; Kortylewski M; Majka M
Cell Death Dis; 2018 May; 9(6):643. PubMed ID: 29844345
[TBL] [Abstract][Full Text] [Related]
37. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
38. Stress-induced C/EBP homology protein (CHOP) represses MyoD transcription to delay myoblast differentiation.
Alter J; Bengal E
PLoS One; 2011; 6(12):e29498. PubMed ID: 22242125
[TBL] [Abstract][Full Text] [Related]
39. Tip60 regulates myoblast differentiation by enhancing the transcriptional activity of MyoD via their physical interactions.
Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
FEBS J; 2011 Nov; 278(22):4394-404. PubMed ID: 21936881
[TBL] [Abstract][Full Text] [Related]
40. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
